Alfredo Delgado-Rivas
Villarroel St. 170
Barcelona, CT 08036, Spain
Barcelona, CT 08036, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Tumor CD19 Expression Determines Distinct Clinical Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.
Journal: Blood cancer discovery
Published: January 04, 2026
Impact of fludarabine exposure on CAR T-cell outcomes in patients with large B-cell lymphoma.
Journal: Blood advances
Published: December 04, 2025
Impact of fludarabine exposure on CAR T-cell outcomes in patients with large B-cell lymphoma.
Journal: Blood advances
Published: December 04, 2025
Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy.
Journal: Pharmaceutics
Published: October 27, 2025
Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-cell Therapy in Large B-Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: September 03, 2025
Landmark-Based Evaluations of Long-Term Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: September 03, 2025
Validation of prognostic scores in patients with HIV-related diffuse large B-cell lymphoma: The value of peripheral blood parameters-A study from the Spanish Lymphoma Group GELTAMO.
Journal: British journal of haematology
Published: July 16, 2025
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma.
Journal: Blood advances
Published: April 09, 2025
Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience.
Journal: British journal of haematology
Published: March 20, 2025
Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.
Journal: Leukemia
Published: January 03, 2025
Last Updated: 09/26/2026